Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$56.61 - $80.46 $5.23 Million - $7.43 Million
-92,305 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $8,881 - $12,894
103 Added 0.11%
92,305 $8.58 Million
Q4 2020

Feb 11, 2021

BUY
$79.17 - $111.47 $1.1 Million - $1.55 Million
13,898 Added 17.75%
92,202 $8.26 Million
Q3 2020

Nov 10, 2020

SELL
$81.91 - $134.94 $2.42 Million - $3.98 Million
-29,523 Reduced 27.38%
78,304 $8.09 Million
Q2 2020

Aug 11, 2020

SELL
$54.33 - $89.52 $1.1 Million - $1.81 Million
-20,164 Reduced 15.75%
107,827 $8.53 Million
Q1 2020

May 13, 2020

SELL
$49.34 - $68.76 $686,664 - $956,932
-13,917 Reduced 9.81%
127,991 $7.41 Million
Q4 2019

Feb 11, 2020

SELL
$51.21 - $59.06 $1.7 Million - $1.96 Million
-33,150 Reduced 18.94%
141,908 $7.66 Million
Q3 2019

Nov 12, 2019

SELL
$40.6 - $57.2 $2.2 Million - $3.1 Million
-54,268 Reduced 23.66%
175,058 $9.15 Million
Q2 2019

Aug 13, 2019

SELL
$39.92 - $53.86 $1.54 Million - $2.08 Million
-38,579 Reduced 14.4%
229,326 $11.1 Million
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $821,983 - $1.13 Million
17,043 Added 6.79%
267,905 $13.5 Million
Q4 2018

Feb 14, 2019

BUY
$55.63 - $73.24 $7.96 Million - $10.5 Million
143,023 Added 132.63%
250,862 $14.9 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $203,359 - $259,854
-3,907 Reduced 3.5%
107,839 $7.1 Million
Q2 2018

Aug 01, 2018

SELL
$48.33 - $55.64 $607,701 - $699,617
-12,574 Reduced 10.11%
111,746 $0
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $5.52 Million - $6.76 Million
124,320 New
124,320 $6.55 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.